WORLD'S LARGEST MARKET RESEARCH RESOURCE — 1,519,265 REPORTS

 
 
• SEARCH FOR A REPORT

Search Results

Search
Enter keywords, a title or a report id number below.
Advanced

• SELECT SITE CURRENCY

Select a currency for use throughout the site



Your Search for 'Allergan: Performance, Products, Pipeline and Potential' returned 33 results - Page 1 of 2

Sort by

Sorted by Rank Top-Bottom
  • Allergan, Inc. (AGN) - Financial and Strategic SWOT Analysis Review

    GlobalData, Apr 2011 , Pages: 52
    Allergan, Inc. - Key Facts Allergan, Inc. - Key Employees Allergan, Inc. - Key Employee Biographies Allergan, Inc. - Major Products and Services Allergan, Inc. - Medical Equipment Pipeline Products ...
  • Allergan, Inc. Product Pipeline Analysis

    Global Markets Direct, May 2008 , Pages: 55
    Allergan, Inc. Product Pipeline Analysis Summary This report is an insightful source for data, analysis and strategic insights into a Allergan, Inc.’s pipeline and investigational products. The ...
  • Glaucoma Therapeutics - Pipeline Assessment and Market Forecasts to 2018

    GlobalData, Sep 2011 , Pages: 94
    review of pipeline products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global ...
  • Big Pharma's Key Lifecycle Management Strategies - Maximizing the Market Potential

    GBI Research, Feb 2010 , Pages: 85
    4.3 Drought in the R&D Pipeline Products (Low R&D Productivity) 4.4 Stricter FDA Rules and Regulations for Drug Approval 4.5 Restriction on Pricing and Reimbursement of Originals 4.6 Changing ...
  • Drug Repositioning: New Technologies, Business Models & Strategies for Successful Development

    Arrowhead Publishers, Oct 2011 , Pages: 155
    leading products and pipeline candidates in the market? - How much revenue will the leading products and key pipeline agents reach by 2016? - What financial rewards does the strategy provide? - What ...
  • Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019

    GlobalData, May 2012 , Pages: 77
    insights on the pipeline products within the global Retinal Vein Occlusion Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary ...
  • Top 50 Pharmaceutical Companies & Their Pipelines 2011

    UBM Canon, Sep 2011 , Pages: 234
    U.S. and EU as well as FDA approval for generic Enoxaparin. The Swiss company has at least seven more potential blockbusters in the pipeline. The following information is included for the top 50 ...
  • Uveitis Therapeutics - Pipeline Assessment and Market Forecasts to 2017

    GlobalData, Apr 2011 , Pages: 63
    products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global uveitis market. - Drive ...
  • The Global Pain Therapeutics Market, 4th Edition: Market Trends & R&D Insights

    Arrowhead Publishers, Oct 2010 , Pages: 385
    Markets, 2008-2020 Table 33: Late-Stage and Phase II Back Pain Therapeutics Pipeline, 2010 Table 34: Potential Pain Biomarkers Table 35: Pain Therapeutics Investigated by fMRI Table 36: Current Late ...
  • Postherpetic Neuralgia (PHN) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

    GlobalData, Jun 2011 , Pages: 74
    valuable insights on the pipeline products within the global Postherpetic Neuralgia Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and ...
  • ACADIA Pharmaceuticals Inc. (ACAD) - Financial and Strategic SWOT Analysis Review

    GlobalData, Apr 2013 , Pages: 40
    . - Key Employees ACADIA Pharmaceuticals Inc. - Key Employee Biographies ACADIA Pharmaceuticals Inc. - Major Products and Services ACADIA Pharmaceuticals Inc. - Pharmaceutical Pipeline Products ...
  • Diquas (Dry Eye Syndrome) - Analysis and Forecasts to 2022

    GlobalData, Jun 2012 , Pages: 24
    details which influence its sales potential - Detailed sales forecast for 2012-2022 for Diquas in Japan Reasons to buy - Understand and capitalize by identifying products that are most likely to ensure a ...
  • Noven Pharmaceuticals, Inc. - Strategic SWOT Analysis Review

    GlobalData, Feb 2013 , Pages: 23
    academic or business research needs. - Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business ...
  • Halozyme Therapeutics, Inc. (HALO) - Financial and Strategic SWOT Analysis Review

    GlobalData, Mar 2013 , Pages: 40
    Halozyme Therapeutics, Inc., Major Products and Services Halozyme Therapeutics, Inc., Number of Pipeline Products by Therapy Area Halozyme Therapeutics, Inc., Number of Pipeline Products by Development ...
  • Mentor Worldwide LLC - Strategic SWOT Analysis Review

    GlobalData, Feb 2013 , Pages: 23
    Worldwide LLC - Major Products and Services Mentor Worldwide LLC - Medical Equipment Pipeline Products Data Mentor Worldwide LLC Pipeline Products by Equipment Type Mentor Worldwide LLC Pipeline ...
  • Restasis (Dry Eye Syndrome) - Analysis and Forecasts to 2022

    GlobalData, Jun 2012 , Pages: 33
    drugs with the most promising sales potential - Make more informed business decisions from insightful and in-depth analysis of the drug’s performance - Examine the historical sales performance of a drug ...
  • ISTA Pharmaceuticals, Inc. (ISTA) - Financial and Strategic SWOT Analysis Review

    GlobalData, Sep 2011 , Pages: 38
    pain, glaucoma and ocular and nasal allergies. The company also has several products in its development pipeline. Its marketed products include: Bromday, Xibrom, Bepreve, Istalol and Virtase. Products in ...
  • 4SC AG (VSC) - Financial and Strategic SWOT Analysis Review

    GlobalData, Sep 2011 , Pages: 38
    get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and ...
  • Q-Med AB (QMED) - Financial and Strategic SWOT Analysis Review

    GlobalData, Sep 2011 , Pages: 40
    technological threats are highlighted. Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. - Financial ratio ...
  • Medicis Pharmaceutical Corporation (MRX) - Financial and Strategic SWOT Analysis Review

    GlobalData, Sep 2011 , Pages: 41
    its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key ...
Results: First - Prev - 1 - 2 - Next - Last